Tamara A Seymour - Net Worth and Insider Trading

Tamara A Seymour Net Worth

The estimated net worth of Tamara A Seymour is at least $3,530 dollars as of 2024-05-15. Tamara A Seymour is the Director of Zevra Therapeutics Inc and owns about 719 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $3,530. Details can be seen in Tamara A Seymour's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tamara A Seymour has not made any transactions after 2023-03-17 and currently still holds the listed stock(s).

Transaction Summary of Tamara A Seymour

To

Tamara A Seymour Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tamara A Seymour owns 4 companies in total, including Viridian Therapeutics Inc (VRDN) , Zevra Therapeutics Inc (ZVRA) , and Kintara Therapeutics Inc (KTRA) among others .

Click here to see the complete history of Tamara A Seymour’s form 4 insider trades.

Insider Ownership Summary of Tamara A Seymour

Ticker Comapny Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2015-08-04 CFO & Secretary & Treasurer
ZVRA Zevra Therapeutics Inc 2023-03-17 director
KTRA Kintara Therapeutics Inc 2021-04-29 director
2021-03-03 director

Tamara A Seymour Latest Holdings Summary

Tamara A Seymour currently owns a total of 1 stock. Tamara A Seymour owns 719 shares of Zevra Therapeutics Inc (ZVRA) as of March 17, 2023, with a value of $3,530.

Latest Holdings of Tamara A Seymour

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZVRA Zevra Therapeutics Inc 2023-03-17 719 4.91 3,530

Holding Weightings of Tamara A Seymour


Tamara A Seymour Form 4 Trading Tracker

According to the SEC Form 4 filings, Tamara A Seymour has made a total of 2 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 519 shares on March 17, 2023, which cost Tamara A Seymour around $2,502.

Insider Trading History of Tamara A Seymour

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tamara A Seymour Trading Performance

GuruFocus tracks the stock performance after each of Tamara A Seymour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tamara A Seymour is 16.45%. GuruFocus also compares Tamara A Seymour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tamara A Seymour within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tamara A Seymour's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tamara A Seymour

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.97
Relative Return to S&P 500(%) 7.88

Tamara A Seymour Ownership Network

Ownership Network List of Tamara A Seymour

No Data

Ownership Network Relation of Tamara A Seymour


Tamara A Seymour Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Tamara A Seymour is the CFO & Secretary & Treasurer of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Gp Llc , director & President and CEO Stephen F. Mahoney , and Chief Operating Officer Thomas W. Beetham .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Tamara A Seymour made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 81,389 shares made by Lara Meisner , a net sale of 100,000 shares made by Jonathan Violin , and a net sale of 89,000 shares made by Barrett Katz .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 270,389 shares of Viridian Therapeutics Inc (VRDN) were sold and 485,690 shares were bought by its insiders, resulting in a net purchase of 215,301 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Tamara A Seymour Mailing Address

Above is the net worth, insider trading, and ownership report for Tamara A Seymour. You might contact Tamara A Seymour via mailing address: C/o Signal Genetics, Inc., 5740 Fleet Street, Carlsbad Ca 92008.

Discussions on Tamara A Seymour

No discussions yet.